EPISODE · Sep 16, 2025 · 54 MIN
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management
from Hematologic Oncology Update
Dr Neel Pasricha from the University of California, San Franciso, reviews corneal and other ophthalmic toxicities associated with antibody-drug conjugates and other cancer therapies and strategies for their prevention and management. CME information and select publications here.
Embed this episode
NOW PLAYING
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management
0:00
54:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Hematologic Oncology Update?
This episode is 54 minutes long.
When was this Hematologic Oncology Update episode published?
This episode was published on September 16, 2025.
Can I download this Hematologic Oncology Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!